Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0011-01
Published November 4, 2020 · Recall initiated: October 5, 2020
Summary
FDA records drug Class II recall D-0053-2021, published November 4, 2020 and initiated October 5, 2020. Recalling firm: Boehringer Ingelheim Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: N/A; Lot: Lot # 954953, EXP Jan 2022. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
An extraneous peak was observed for dissolution testing.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Distributor
- Distributed Nationwide in the USA and Puerto Rico
- Lot
- Lot # 954953, EXP Jan 2022
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASynjardy XR Tablets (empagliflozin and metformin hydrochloride extended-release tablets), 12.5/1000 mg, 60July 8, 2026
- FDAJARDIANCE (Empagliflozin), 25 mg Tablets, packaged in a) 30-count (NDC0597-0153-30) and b) 90-count (NDCMarch 29, 2023
- FDAMicardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37),June 9, 2021
- FDACatapres (clonidine hydrochloride, USP) 0.2 mg, tablet, 100-count bottle, Rx only, Dist. by: BoehringerNovember 4, 2020
- FDAHydrocortisone butyrate Cream, 0.1%, 15-gram tubes, Rx Only, Manufactured for Oceanside Pharmaceuticals aNovember 4, 2020
- FDACatapres (clonidine hydrochloride, USP) 0.1 mg, tablet, 100-count bottle, Rx only, Dist. by: BoehringerNovember 4, 2020
Questions about this recall
Was Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet, 100-count bottle, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877, Made in Germany, NDC, 0597-0011-01 recalled?
Yes. FDA published recall D-0053-2021 on November 4, 2020. Reported hazard: An extraneous peak was observed for dissolution testing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter